SciELO - Scientific Electronic Library Online

 
vol.13 issue1Uterine niche: implications in gynecologyDoença de McArdle e Gravidez author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Acta Obstétrica e Ginecológica Portuguesa

Print version ISSN 1646-5830

Abstract

VEIGA, Vera; CORREIA, Lúcia; GOMES, António  and  JORGE, Ana Francisca. Hormonal therapy post ovarian cancer treatment: yes or no?. Acta Obstet Ginecol Port [online]. 2019, vol.13, n.1, pp.40-46. ISSN 1646-5830.

The mean age of diagnosis of ovarian epithelial tumors is 63 years, but 3-17% affects women under the age of 40 years. In this age group, standard treatment conditions an iatrogenic menopause, so that conservative therapeutic options are increasingly weighted at early ages. Estrogen therapy is the most effective treatment for the symptoms associated with menopause, but doubts about its use in these women are frequent. The review of the literature shows that after treatment of ovarian cancer, the use of hormone therapy does not influence relapse rates nor overall survival.

Keywords : Ovary cancer; Hormonal; Contraception; Recurrence; Receptors.

        · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License